CHRISTOPHER VERRICO

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
Address2002 HOLCOMBE
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pharmacology and Chemical Biology
    DivisionPharmacology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yammine L, Green CE, Kosten TR, de Dios C, Suchting R, Lane SD, Verrico CD, Schmitz JM. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: a Pilot Randomized Controlled Trial. Nicotine Tob Res. 2021 Apr 08. PMID: 33831213.
      Citations:    
    2. Verrico CD, Wesson S, Konduri V, Hofferek CJ, Vazquez-Perez J, Blair E, Dunner K, Salimpour P, Decker WK, Halpert MM. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain. 2020 Sep 01; 161(9):2191-2202. PMID: 32345916.
      Citations: 5     Fields:    
    3. Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 Dec; 108(6):1203-1212. PMID: 32496573.
      Citations:    Fields:    
    4. Saxena K, Verrico CD, Saxena J, Kurian S, Alexander S, Kahlon RS, Arvind RP, Goldberg A, DeVito N, Baig M, Grieb A, Bakhshaie J, Simonetti A, Storch EA, Williams L, Gillan L. An Evaluation of Yoga and Meditation to Improve Attention, Hyperactivity, and Stress in High-School Students. J Altern Complement Med. 2020 Aug; 26(8):701-707. PMID: 32551827.
      Citations:    Fields:    Translation:Humans
    5. Verrico CD, Mathai DS, Gu H, Sampson AR, Lewis DA. Recovery from impaired working memory performance during chronic ?-9-tetrahydrocannabinol administration to adolescent rhesus monkeys. J Psychopharmacol. 2020 02; 34(2):211-220. PMID: 31621487.
      Citations: 1     Fields:    Translation:Animals
    6. Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R, Kosten TR, Verrico CD. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. Am J Addict. 2019 11; 28(6):455-464. PMID: 31483544.
      Citations: 1     Fields:    Translation:Humans
    7. Patel M, Verrico CD, De La Garza R. Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacol Biochem Behav. 2019 10; 185:172758. PMID: 31430484.
      Citations:    Fields:    Translation:Humans
    8. Ma YJ, Wang DF, Yuan M, Zhang XJ, Long J, Chen SB, Wu QX, Wang XY, Patel M, Verrico CD, Liu TQ, Zhang XY. The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder. BMC Psychiatry. 2019 05 10; 19(1):144. PMID: 31077181.
      Citations: 3     Fields:    Translation:Humans
    9. Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573. PMID: 30126012.
      Citations: 1     Fields:    Translation:Humans
    10. Deng H, Verrico CD, Kosten TR, Nielsen DA. Psychosis and synthetic cannabinoids. Psychiatry Res. 2018 10; 268:400-412. PMID: 30125871.
      Citations: 6     Fields:    Translation:HumansAnimals
    11. Mathai DS, Holst M, Rodgman C, Haile CN, Keller J, Hussain MZ, Kosten TR, Newton TF, Verrico CD. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. J Neuropsychiatry Clin Neurosci. 2018; 30(1):66-76. PMID: 28641496.
      Citations: 3     Fields:    Translation:Humans
    12. Mathai DS, Verrico CD, Shorter D, Coverdale JH, Kosten TR. "Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents. Am J Addict. 2016 12; 25(8):620-622. PMID: 27749024.
      Citations:    Fields:    
    13. Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7). PMID: 27207905.
      Citations: 4     Fields:    Translation:Humans
    14. Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May; 77(5):e561-5. PMID: 27249080.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    15. De La Garza R, Verrico CD, Newton TF, Mahoney JJ, Thompson-Lake DG. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2015 Sep 12; 19(3):pyv098. PMID: 26364275.
      Citations: 1     Fields:    Translation:Humans
    16. Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9. PMID: 26239766.
      Citations: 2     Fields:    Translation:Humans
    17. Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6. PMID: 25424624.
      Citations: 20     Fields:    Translation:Humans
    18. Rodgman CJ, Verrico CD, Worthy RB, Lewis EE. Inpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone. Prim Care Companion CNS Disord. 2014; 16(4). PMID: 25664202.
      Citations: 4     Fields:    
    19. Kalechstein AD, Mahoney JJ, Verrico CD, De La Garza R. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 2014 Oct; 85:493-8. PMID: 24930359.
      Citations: 3     Fields:    Translation:Humans
    20. Verrico CD, Haile CN, Mahoney JJ, Thompson-Lake DG, Newton TF, De La Garza R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 Aug 01; 141:72-8. PMID: 24928479.
      Citations: 12     Fields:    Translation:Humans
    21. Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71. PMID: 24951161.
      Citations: 13     Fields:    Translation:Humans
    22. Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. Repeated ?9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry. 2014 Apr; 171(4):416-25. PMID: 24577206.
      Citations: 19     Fields:    Translation:Animals
    23. Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33. PMID: 24393456.
      Citations: 7     Fields:    Translation:Humans
    24. Mahoney JJ, Kalechstein AD, Verrico CD, Arnoudse NM, Shapiro BA, De La Garza R. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42. PMID: 24239594.
      Citations: 4     Fields:    Translation:Humans
    25. Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013 Dec; 22(12):1549-68. PMID: 24033127.
      Citations: 15     Fields:    Translation:HumansAnimals
    26. Volk DW, Siegel BI, Verrico CD, Lewis DA. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophr Res. 2013 Jun; 147(1):53-57. PMID: 23561296.
      Citations: 16     Fields:    Translation:HumansAnimals
    27. Verrico CD, Liu S, Bitler EJ, Gu H, Sampson AR, Bradberry CW, Lewis DA. Delay- and dose-dependent effects of ??-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. Neuropsychopharmacology. 2012 May; 37(6):1357-66. PMID: 22218091.
      Citations: 11     Fields:    Translation:Animals
    28. Verrico CD, Liu S, Asafu-Adjei JK, Sampson AR, Bradberry CW, Lewis DA. Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. Brain Res. 2011 Mar 10; 1378:91-104. PMID: 21215729.
      Citations: 10     Fields:    Translation:Animals
    29. Eggan SM, Stoyak SR, Verrico CD, Lewis DA. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology. 2010 Sep; 35(10):2060-71. PMID: 20555313.
      Citations: 39     Fields:    Translation:HumansAnimals
    30. Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. J Psychopharmacol. 2008 Mar; 22(2):187-202. PMID: 18308800.
      Citations: 10     Fields:    Translation:AnimalsCells
    31. Verrico CD, Miller GM, Madras BK. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology (Berl). 2007 Jan; 189(4):489-503. PMID: 16220332.
      Citations: 53     Fields:    Translation:HumansCells
    32. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK. Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther. 2005 Jun; 313(3):983-94. PMID: 15764732.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    33. Verrico CD, Jentsch JD, Roth RH, Taylor JR. Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology. 2004 Mar; 29(3):522-9. PMID: 14694348.
      Citations: 15     Fields:    Translation:Animals
    34. Verrico CD, Jentsch JD, Roth RH. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse. 2003 Jul; 49(1):61-6. PMID: 12710016.
      Citations: 15     Fields:    Translation:Animals
    35. Verrico CD, Jentsch JD, Dazzi L, Roth RH. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. Synapse. 2003 Jun 15; 48(4):178-83. PMID: 12687636.
      Citations: 8     Fields:    Translation:Animals
    36. De La Garza R, Jentsch JD, Verrico CD, Roth RH. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Res. 2002 Dec 20; 958(1):20-7. PMID: 12468026.
      Citations: 4     Fields:    Translation:Animals
    37. George TP, Picciotto MR, Verrico CD, Roth RH. Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects. Biol Psychiatry. 2001 Feb 01; 49(3):300-6. PMID: 11230881.
      Citations: 1     Fields:    Translation:Animals
    38. George TP, Verrico CD, Picciotto MR, Roth RH. Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther. 2000 Oct; 295(1):58-66. PMID: 10991961.
      Citations: 19     Fields:    Translation:Animals
    39. George TP, Verrico CD, Xu L, Roth RH. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. Neuropsychopharmacology. 2000 Jul; 23(1):79-88. PMID: 10869888.
      Citations: 4     Fields:    Translation:Animals
    40. Jentsch JD, Dazzi L, Chhatwal JP, Verrico CD, Roth RH. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci Lett. 1998 Dec 24; 258(3):175-8. PMID: 9885959.
      Citations: 18     Fields:    Translation:Animals
    41. George TP, Verrico CD, Roth RH. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Res. 1998 Aug 10; 801(1-2):36-49. PMID: 9729261.
      Citations: 6     Fields:    Translation:Animals
    42. Jentsch JD, Verrico CD, Le D, Roth RH. Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neurosci Lett. 1998 May 01; 246(3):169-72. PMID: 9792619.
      Citations: 14     Fields:    Translation:Animals
    43. Fernstrom MH, Verrico CD, Ebaugh AL, Fernstrom JD. Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain. Life Sci. 1996; 58(17):1433-44. PMID: 8622569.
      Citations: 2     Fields:    Translation:AnimalsCells
    VERRICO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (228)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _